Berlin Heart Announces Restructuring of Management

BERLIN, July 7 /PRNewswire/ -- Ulrich Stroeher, Chairman of the Advisory Board of Berlin Heart, today announced that Dr. Johannes Mueller is leaving the general management of the company on 30 September 2009. Dr. Mueller belongs to the company's founders and is one of the intellectual f...

Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. Announce Restructuring Changes Aimed at Growing Otsuka's Pharmaceutical Business Worldwide

Restructuring efforts include the re-alignment of shared services, including Business Technology, and establishment of Pharmaceutical Governance and Medical Device Governance Committees ROCKVILLE, Md. and PRINCETON, N.J., Feb. 25 /PRNewswire/ -- Otsuka America Pharmaceutical, Inc. (OAPI) and ...

Vical Announces Strategic Restructuring and Staff Reduction

SAN DIEGO, Nov. 21 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL ) today announced a strategic restructuring including a staff reduction of 29 employees, approximately 20% of the company's total workforce, and accelerated closure of a research facility. Following the restructuring, ...

Replidyne Announces Restructuring of Operations

LOUISVILLE, Colo., Aug. 27 /PRNewswire-FirstCall/ -- Replidyne, Inc. (Nasdaq: RDYN ) today announced the restructuring of its operations reducing its current employee headcount by approximately 80% to 5 employees in actions that are scheduled to take place during September 2008 and October 20...

Aduromed Closes Restructuring and Raises $3.8 Million of New Equity Capital

Aduromed Begins Next Step in Corporate Evolution, Restructuring the Company and Augmenting its Board and Management Team BETHEL, Conn., Aug. 6 /PRNewswire-FirstCall/ -- Aduromed Industries, Inc. (OTC Bulletin Board: ADRM) a leading manufacturer of medical waste treatment systems, to...

Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, March 3, 2008

BOTHELL, Wash., Feb. 29 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK ) announced today that it will host a conference call with investors and security analysts on Monday, March 3, 2008, at 11:30 a.m. Eastern time (8:30 a.m. Pacific time) to discuss the Company's...

IDM Pharma Announces Termination of UVIDEM Development Collaboration and Expected Restructuring in Connection With Evaluation of Strategic Alternatives

IRVINE, Calif., Dec. 31 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (Nasdaq: IDMI ) today announced that as part of the Company's recent decision to evaluate strategic alternatives, the Company initiated discussions with sanofi-aventis. Following this, sanofi-aventis has notified the Company o...

Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs

Company to Host Webcast and Conference Call BOTHELL, Wash., Nov. 13 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. ("Nastech") (Nasdaq: NSTK ) announced today its corporate restructuring initiatives aimed at reducing operating expenses and enhancing shareholder va...

Brotman Medical Center Facilitates Restructuring Through Chapter 11 Filing

CULVER CITY, Calif., Oct. 26 /PRNewswire/ -- Brotman Medical Center, a privately held, 420-bed medical center serving the West Los Angeles area, announced today that it has filed a voluntary Chapter 11 petition in the United States Bankruptcy Court for the Central District of California in Los...

QLT Inc. announces initial steps in strategic restructuring

VANCOUVER, Jan. 16 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) today announced that following a months-long business and portfolio review, the Board of Directors has decided to implement several new initiatives designed to enhance shareholder value. These initiatives include...

Restructuring in Medical Technology

Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring

Conference Call Scheduled for November 11, 2008 at 9:00 am ET SOUTH SAN FRANCISCO, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV ) today announced that the ACTIVE-1 Phase 3 trial evaluating Adlea(TM), a novel formulation of capsaicin, narrowly missed its primary e...

Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status

...ry focus on the continued development of AZ-004 ( Staccato loxapine). The restructuring included a workforce reduction of 50 employees, representing approximately ... General and administrative 3,864 4,462 restructuring charges 1,528 - Acquired in-pro...

Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update

...r of 2009 include a charge of $1.1 million for the restructuring and related asset impairment resulting from the Company's strategic restructuring plan to discontinue its in-house preclinical resea...d administrative 3,084 4,183 restructuring & asset impairment 1,056 - ...

Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments

...42,710 245,745 General and administrative(b) 14,860 16,125 60,865 55,874 Lease termination and restructuring credits - - - (3,673) Total costs and expenses 63,376 103,437 303,575 ...

Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results

...ain the company's emphasis on its active preclinical and clinical programs, while conserving the company resources. The company is still assessing the restructuring and other charges associated with this measure, which is expected to be predominantly recorded in the first quarter of 2009. As of December 31, 2008, ...

American Dairy Provides Business Update

... The Company also announced that, as part of the restructuring of the Company's outstanding 1% Guaranteed Senior ...pended, as of November 13, 2008, the date that the restructuring took effect, provided that the Company completes t...fied deadlines in accordance with the terms of the restructuring agreement. In the event that the Company does not...

Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company

..., president and CEO. "Based on this review we are refining our strategy and restructuring operations to drive the company toward long-term success." "We believe th...elopment and outsourced manufacturing. Anesiva expects to record a one-time restructuring charge of approximately $0.7 million in the third quarter of 2008. Anesiva ...

CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE

... Research and development 3,635 10,904 9,006 22,406 General and administrative 1,443 3,049 3,159 7,063 restructuring and other charges - 7,479 - 7,479 Total operating expenses 5,078 21,432 12,165 36,948 Gain on sale of...

Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)

...search facility. Approximately $2.5 million of the restructuring charge represents cash payments over the next twel...lated to the expected timing for completion of the restructuring plan; estimated restructuring charges to be incurred by Sunesis in the second qu...

Neurocrine Biosciences Reports First Quarter 2008 Results

...ch and development expenses is primarily due to cost savings related to our restructuring in the fourth quarter of 2007. General and administrative expenses were $...lion during the same period last year. The Company incurred $2.2 million in restructuring charges during the first quarter of 2008. This cost was offset by cost savi...

Restructuring in Biological News

Public trust doctrine could aid management of US oceans

...ould be an effective and ethical solution to this and similar conflicts. "The public trust doctrine could provide a practical legal framework for restructuring the way we regulate and manage our oceans. It would support ocean-based commerce while protecting marine species and habitats," says lead author Mary ...

Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008

...xcluding the effects of the net change in accrued restructuring charges Revenues for the fourth...ion, generated $12 million of cash flow (excluding restructuring charges), and increased our subscription based pro... write-down of long-term assets and adjustments to restructuring accruals. See the financial table below reconcilin...

CSHL researchers map changing epigenetic modifications that enable transposons to run amok

... shouldn't be and shut off the activity of genes that are essential. The team's epigenetic profiling study now implicates siRNA-driven heterochromatin restructuring as a mechanism that might lead to epiallele formation. ...

Orchid Cellmark Reports Third Quarter 2008 Financial Results

...ting and sales 1,536 1,503 4,659 4,500 General and administrative 3,588 3,831 12,639 11,747 restructuring - (75) - (75) Amortization of intangible assets 475 447 1,429 1,337 Total...

Entomological Society of America names new Fellows for 2008

...h Central Branch (1998), on the Governing Board (1990-1993, 2000-2005), as ESA President (2004), and as a member of numerous committees, including the restructuring Advisory Council (2006-2007). He was co-editor of the ESA's Handbook of Corn Insects , published in 1999. "I have been recognized several times by th...

Cocaine: How addiction develops

...s in the brain: In particular regions of the central nervous system, which produce the messenger substance dopamine, the drug cocaine causes molecular restructuring processes at the synapses, the points of connection between two neurons. As a reaction to the drug, protein subunits are exchanged in specific recepto...

Shell-breaking crabs lived 20 million years earlier than thought

...esearch Institution in Ithaca. "I was really excited when I found it. The fossil re-opens the question of the role crabs played in the well-documented restructuring of marine communities that occurred during the Mesozoic era [251 million years ago to 65 million years ago]." The discovery led to a study, publish...

Is hybridoma production about to take a quantum leap forward?

...blocked by the basic difference between regular water and intracellular water, can now cross the "molecular water barrier", thanks to the nanoparticle restructuring capability of Neowater®. We can expect a new era in R&D as these concepts are facilitated by Neowater® technology and find realization in the...

Recovering from a mass extinction

...s with a backbone and four legs, such as amphibians and reptiles and found that although globally tetrapods appeared to recover quickly, the dramatic restructuring that occurred at the community level was not permanent and communities did not recover numerically or ecologically until about 30 million years later....

Oak Ridge to lead auto supplier R&D partnership

...enter with established laboratory infrastructure that will support up to 175 people. Delphi Corporation is vacating this facility under its corporate restructuring program. An organizing board has been formed to govern USAutoPARTs and its research mission. Those participating include: Automation Alley, the Cen...

Restructuring in Biological Technology

Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598

SAN DIEGO, June 4 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) today announced a strategic restructuring to focus its operations on the development of ANA598, in particular a proposed Phase II study in hepatitis C patients of ANA598 in combination with pegylated int...

Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock

MONTVALE, N.J., Feb. 24 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) today announced that it has entered into agreements with the current holders of its Series B Preferred Stock, $0.01 par value per share, under which $2,875,000 in accrued dividend obligations r...

XTL Biopharmaceuticals Implements Restructuring Plan

VALLEY COTTAGE, N.Y., Dec. 8 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) announced today that it is restructuring its operations following the failure of the Bicifadine Phase 2b clinical trial. The company is terminating the employment of 9 employees, represe...

Amylin Pharmaceuticals Announces Strategic Restructuring and Workforce Reduction

Changes will result in over $80 million reduction in 2009 cash expenditures SAN DIEGO, Nov. 10 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today announced a corporate restructuring that will reduce its San Diego workforce by approximately 25 percent, or 340 employees,...

ADVENTRX Announces Restructuring and Cost Reduction Initiatives

- CEO Resigns; Executive Team Reorganized; 27% Reduction in Force - Timelines Revised for ANX-530 and ANX-514 - Company to Present Updated Corporate Outlook at Conferences in October SAN DIEGO, Oct. 20 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX ) ann...

Vasogen Announces Implementation of Strategic Restructuring Plan

MISSISSAUGA, ON, April 14 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ: VSGN ; TSX:VAS), today announced that it has implemented a strategic restructuring plan to significantly reduce its cash burn rate and focus its efforts on opportunities that the Board and management believe are most like...

Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan

Plan includes refocusing of operations and workforce reduction NEW YORK, April 4, 2008 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals (Nasdaq: KERX ) today announced that it is implementing a strategic restructuring plan to reduce its cash burn rate and re-focus its development effor...

Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization

SAN CARLOS, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR ) announced a restructuring today designed to complete its transition from a drug delivery service provider to a therapeutics drug development organization. The restructuring will streamline the company, c...

Neurocrine Announces Work Force Restructuring

SAN DIEGO, May 5 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today staff reductions of approximately 60 employees, as a part of its restructuring program to focus the Company's efforts on its clinical programs and pre-clinical development leads. Following th...

Trubion Pharmaceuticals Inc. Announces Work-Force Reductions and Restructuring

SEATTLE, Feb. 25 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals Inc. (Nasdaq: TRBN ) today announced a work-force reduction of approximately 25 percent, or 25 employees, and a corporate restructuring. In the face of continuing uncertainty in the capital markets and the global economy, Tru...

Restructuring in Biological Definition

Gastrula

...f embryonic development is seen in all animals except the sponges . It follows the blastula phase. The gastrula phase is marked by a dramatic restructuring called gastrulation . After gastrulation is complete, the embryo develops into a neurula . ...